{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T10:19:02Z","timestamp":1783073942718,"version":"3.54.6"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.cgh.2015.09.041","type":"journal-article","created":{"date-parts":[[2015,10,24]],"date-time":"2015-10-24T18:35:38Z","timestamp":1445711738000},"page":"413-420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Increased Risk of Oral Cancer in Patients With Inflammatory Bowel Diseases"],"prefix":"10.1016","volume":"14","author":[{"given":"Konstantinos H.","family":"Katsanos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Roda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell B.","family":"McBride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fr\u00e9d\u00e9ric","family":"Colombel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2015.09.041_bib1","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.4317\/medoral.18772","article-title":"Oral cancer: current role of radiotherapy and chemotherapy","volume":"18","author":"Huang","year":"2013","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"10.1016\/j.cgh.2015.09.041_bib2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1758-3284-1-8","article-title":"Controversies surrounding human papilloma virus infection, head & neck vs oral cancer, implications for prophylaxis and treatment","volume":"1","author":"Campisi","year":"2009","journal-title":"Head Neck Oncol"},{"key":"10.1016\/j.cgh.2015.09.041_bib3","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0964-1955(95)00031-3","article-title":"Metastatic tumours to the oral region. An overview","volume":"31","author":"Hirshberg","year":"1995","journal-title":"Eur J Cancer B Oral Oncol"},{"key":"10.1016\/j.cgh.2015.09.041_bib4","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1056\/NEJM199504203321602","article-title":"Increased prevalence of dysplastic and malignant lip lesions in renal-transplant recipients","volume":"332","author":"King","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2015.09.041_bib5","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1136\/gut.31.4.378","article-title":"Mucosal immunodeficiency in smokers, and in patients with epithelial head and neck tumours","volume":"31","author":"Barton","year":"1990","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2015.09.041_bib6","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1177\/0022034511414156","article-title":"Longitudinal assessment of hematopoietic stem cell transplantation and hyposalivation","volume":"90","author":"Laaksonen","year":"2011","journal-title":"J\u00a0Dent Res"},{"key":"10.1016\/j.cgh.2015.09.041_bib7","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/lt.23778","article-title":"Oral mucosal health in liver transplant recipients and controls","volume":"20","author":"Helenius-Hietala","year":"2014","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2015.09.041_bib8","first-page":"3231","article-title":"Oral bacteria and yeasts in relationship to oral ulcerations in hematopoietic stem cell transplant recipients","volume":"20","author":"Laheij","year":"2012","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.cgh.2015.09.041_bib9","first-page":"28","article-title":"Local presence of cytomegalovirus and Candida species vs oral lesions in liver and kidney transplant recipients","volume":"13","author":"Olczak-Kowalczyk","year":"2008","journal-title":"Ann Transplant"},{"key":"10.1016\/j.cgh.2015.09.041_bib10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.transproceed.2005.12.078","article-title":"Candida-associated denture stomatitis in patients after immunosuppression therapy","volume":"38","author":"Golecka","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.cgh.2015.09.041_bib11","doi-asserted-by":"crossref","first-page":"e49324","DOI":"10.1371\/journal.pone.0049324","article-title":"Oral human papillomavirus in men having sex with men: risk-factors and sampling","volume":"7","author":"Read","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cgh.2015.09.041_bib12","first-page":"S49","article-title":"Role of human papillomaviruses in cutaneous and oral manifestations of immunosuppression","volume":"21","author":"Leigh","year":"1999","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.cgh.2015.09.041_bib13","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1016\/j.vaccine.2013.10.001","article-title":"Comprehensive control of human papilloma virus infections and related diseases","volume":"31","author":"Bosch","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.cgh.2015.09.041_bib14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0300-483X(02)00612-1","article-title":"Immunosuppressive drugs and cancer","volume":"185","author":"Vial","year":"2003","journal-title":"Toxicology"},{"key":"10.1016\/j.cgh.2015.09.041_bib15","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1093\/aje\/kws375","article-title":"Use of azathioprine and the risk of cancer in inflammatory bowel disease","volume":"177","author":"Pasternak","year":"2013","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.cgh.2015.09.041_bib16","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1056\/NEJMra1403718","article-title":"Cancers complicating inflammatory bowel disease","volume":"372","author":"Beaugerie","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2015.09.041_bib17","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00042737-200302000-00013","article-title":"Neoplasia of the tongue in a patient with Crohn's disease treated with azathioprine: case report","volume":"15","author":"Li","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2015.09.041_bib18","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.crohns.2012.03.004","article-title":"Oral squamous cell carcinoma in a Crohn's disease patient taking azathioprine: case report and review of the literature","volume":"6","author":"Vilas-Boas","year":"2012","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.cgh.2015.09.041_bib19","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/MIB.0000000000000338","article-title":"Are patients with inflammatory bowel disease on chronic immunosuppressive therapy at increased risk of cervical high-grade dysplasia\/cancer? A meta-analysis","volume":"21","author":"Allegretti","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2015.09.041_bib20","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cgh.2014.07.036","article-title":"Inflammatory bowel disease and cervical neoplasia: a population-based nationwide cohort study","volume":"13","author":"Rungoe","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2015.09.041_bib21","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1572-0241.2007.01582.x","article-title":"Higher incidence of abnormal Pap smears in women with inflammatory bowel disease","volume":"103","author":"Kane","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2015.09.041_bib22","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.2165\/00003495-200767080-00006","article-title":"Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review","volume":"67","author":"Gutierrez-Dalmau","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.cgh.2015.09.041_bib23","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/S0140-6736(09)61302-7","article-title":"Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study","volume":"374","author":"Beaugerie","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2015.09.041_bib24","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cgh.2014.05.015","article-title":"Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6- mercaptopurine: a meta-analysis","volume":"13","author":"Kotlyar","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2015.09.041_bib25","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1053\/j.gastro.2011.06.050","article-title":"Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease","volume":"141","author":"Peyrin-Biroulet","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2015.09.041_bib26","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1053\/j.gastro.2012.05.004","article-title":"Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease","volume":"143","author":"Long","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2015.09.041_bib27","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/ajg.2013.451","article-title":"Association between thiopurine use and nonmelanoma skin cancers in patients with inflammatory bowel disease: a metaanalysis","volume":"109","author":"Ariyaratnam","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2015.09.041_bib28","doi-asserted-by":"crossref","unstructured":"Bourrier A, Carrat F, Colombel J-F, et\u00a0al. Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory\u00a0bowel disease: a prospective observational cohort study. Aliment Pharmacol Ther 2015 [Epub ahead of print].","DOI":"10.1111\/apt.13466"},{"key":"10.1016\/j.cgh.2015.09.041_bib29","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/0030-4220(92)90209-9","article-title":"Postoperative death of a patient in apparent remission of malignant lymphoma after dissection for squamous cell carcinoma","volume":"74","author":"Noguchi","year":"1992","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.cgh.2015.09.041_bib30","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.3748\/wjg.v20.i13.3525","article-title":"Clinical management of inflammatory bowel disease in the organ recipient","volume":"20","author":"Indriolo","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2015.09.041_bib31","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000353382","article-title":"Use of immunosuppressants and biologicals in patients with previous cancer","volume":"31","author":"Beaugerie","year":"2013","journal-title":"Dig Dis"},{"key":"10.1016\/j.cgh.2015.09.041_bib32","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1093\/annonc\/mdn054","article-title":"A\u00a0clinical study assessing the tolerability and biological effects of infliximab, a TNF-alpha inhibitor, in patients with advanced cancer","volume":"19","author":"Brown","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cgh.2015.09.041_bib33","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1136\/gutjnl-2013-305763","article-title":"Risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancer","volume":"63","author":"Beaugerie","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2015.09.041_bib34","unstructured":"Axelrad J, Bernheim O, Colombel J-F, et\u00a0al. Risk of new or recurrent cancer in patients with inflammatory bowel disease and previous cancer exposed to immunosuppressive and anti-TNF\u03b1 therapy. Clin Gastroenterol Hepatol 2015 [Epub ahead of print]."},{"key":"10.1016\/j.cgh.2015.09.041_bib35","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1556\/oh.2007.28238","article-title":"Malignant tumors following renal transplantation","volume":"148","author":"V\u00e9gso","year":"2007","journal-title":"Orv Hetil"},{"key":"10.1016\/j.cgh.2015.09.041_bib36","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1002\/hed.21650","article-title":"Association of p16(INK4a) overexpression with improved outcomes in young patient with squamous cell cancers of the oral tongue","volume":"33","author":"Harris","year":"2011","journal-title":"Head Neck"},{"key":"10.1016\/j.cgh.2015.09.041_bib37","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1097\/PAS.0000000000000183","article-title":"Keratinizing-type squamous cell carcinoma of the oropharynx: p16 overexpressionis associated with positive high-risk HPV status and improved survival","volume":"38","author":"Cai","year":"2014","journal-title":"Am J Surg Pathol"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356515014172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356515014172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:19:20Z","timestamp":1761542360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356515014172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S1542356515014172"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2015.09.041","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased Risk of Oral Cancer in Patients With Inflammatory Bowel Diseases","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2015.09.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 AGA Institute. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}